WuXi Biologics Competitors and Similar CompaniesClear all
WuXi Biologics's competitors and similar companies include Evotec, Lonza, Samsung Biologics and Fujifilm Diosynth Biotechnologies.
 WuXi Biologics WuXi Biologics (药明生物) is a company operating as an open-access technology platform for biologics drug development. |  Lonza Lonza Group is a company that supplies active ingredients, chemical intermediates, and biotechnology solutions to the pharmaceutical and agrochemical industries. |  Samsung Biologics Samsung Biologics (삼성바이오로직스) is a contract development and manufacturing organization. |  Fujifilm Diosynth Biotechnologies Fujifilm Diosynth Biotechnologies U.S.A. is a contract development and manufacturing organization operating in the biopharmaceutical industry. | ||
Founding Date | Founding Date 2010 | Founding Date 1993 | Founding Date 1897 | Founding Date 2011 | Founding Date 2011 |
Type | Type Public | Type Public | Type Public | Type Public | Type Subsidiary |
Tags | |||||
Locations | Locations Wuxi, CN HQ George Town, KY Wuppertal, DE Hong Kong, HK Dundalk, IE Cranbury, US King Of Prussia, US | Locations Hamburg, DE HQ Orth An Der Donau, AT Lyon, FR Toulouse, FR Göttingen, DE Halle (Westfalen), DE Köln, DE see more | Locations Basel, CH HQ Baulkham Hills, AU Antwerpen, BE Bornem, BE Verviers, BE Rio De Janeiro, BR Dorval, CA see more | Locations Incheon, KR HQ Boston, US Ridgefield Park, US South San Francisco, US | Locations Morrisville, US HQ Hillerød, DK Stockton On Tees, GB College Station, US |
Employees | Employees 12,435 | Employees 5,007 | Employees 17,834 | Employees 4,523 | Employees 5,0151% increase |
Financial | |||||
Revenue (est.) | Revenue (est.) ¥17b (FY, 2023) | Revenue (est.) €781.4m (FY, 2023) | Revenue (est.) CHF6.7b (FY, 2023) | Revenue (est.) ₩3.7t (FY, 2023) | Revenue (est.) N/A |
Cost of goods | Cost of goods ¥8.8b (FY, 2023) | Cost of goods €564.3m (FY, 2023) | Cost of goods CHF4.1b (FY, 2023) | Cost of goods ₩1.9t (FY, 2023) | Cost of goods N/A |
Gross profit | Gross profit ¥8.4b (FY, 2023) | Gross profit €281.9m (FY, 2023) | Gross profit CHF2.6b (FY, 2023) | Gross profit ₩1.8t (FY, 2023) | Gross profit N/A |
Net income | Net income ¥3.6b (FY, 2023) | Net income (€83.9m) (FY, 2023) | Net income CHF655m (FY, 2023) | Net income ₩857.7b (FY, 2023) | Net income N/A |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised $ 993.6m | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 850m |
For sources of this data, please see the company profile
View Company Profiles
Evotec
HQ
Hamburg, DE
Employees
5,007
Evotec is a biotechnology company that provides drug discovery and development services.
View companyLonza
HQ
Basel, CH
Employees
17,834
Lonza Group is a company that supplies active ingredients, chemical intermediates, and biotechnology solutions to the pharmaceutical and agrochemical industries.
View companySamsung Biologics
HQ
Incheon, KR
Employees
4,523
Samsung Biologics (삼성바이오로직스) is a contract development and manufacturing organization.
View companyFujifilm Diosynth Biotechnologies
HQ
Morrisville, US
Fujifilm Diosynth Biotechnologies U.S.A. is a contract development and manufacturing organization operating in the biopharmaceutical industry.
View company